Percutaneous treatment of congenital coronary arteriovenous fistulas

Sivadasanpillai Harikrishnan1, Francis Bimal, Valaparambil Ajithkumar

  • 1Department of Cardiology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, Kerala, India. drharikrishnan@hotmail.com

Insights

Percutaneous closure is a safe and effective treatment for congenital coronary arteriovenous fistulas (CAVF). This minimally invasive approach offers high success rates and low morbidity for patients with these rare heart conditions.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Congenital Heart Disease

Background:

  • Congenital coronary arteriovenous fistulas (CAVF) are rare but can cause significant hemodynamic disturbances.
  • Intervention is often necessary to manage these lesions.

Observation:

  • Six patients (ages 4-49) with CAVF underwent percutaneous transcatheter occlusion.
  • Fistulas originated from various coronary arteries and drained into different heart chambers.
  • Both Cook™ coils and nitinol ductal occluders (NDOs) were utilized for closure.

Findings:

  • Complete fistula occlusion was achieved in all patients.
  • One patient experienced coil migration requiring NDO closure; another had a myocardial infarction post-procedure.
  • Mean follow-up of 39.6 months showed all patients were asymptomatic with no residual fistulae on echo-Doppler.

Implications:

  • Percutaneous closure is a highly successful and safe treatment modality for CAVF.
  • Minimally invasive techniques offer excellent long-term outcomes for patients with congenital coronary arteriovenous fistulas.
Abstract